Scientists have developed a nanopore-based “chop and measure” method that reads peptides one amino acid at a time, potentially opening new paths for disease research, diagnostics, drug development, and personalized medicine.

Editorial Note

This article discusses an experimental peptide-sequencing method published in Nature on July 29, 2026.

The researchers demonstrated single-amino-acid resolution using engineered nanopores, immobilized peptides, repeated electrical measurements, and an enzyme that progressively shortened each peptide. The work represents an early-stage laboratory platform rather than a commercially available diagnostic test or a complete replacement for current proteomics technologies.

Although the method could eventually contribute to medical research and biotechnology, further development will be required to establish its accuracy, speed, scalability, compatibility with complex biological samples, and ability to sequence a broad range of full-length proteins.

Scientists have developed a new way to read peptides one amino acid at a time using a microscopic biological opening known as a nanopore.

The experimental method, described in Nature, combines an engineered nanopore with an enzyme that removes amino acids from one end of a peptide in a carefully controlled sequence.

After each amino acid is removed, the nanopore measures the remaining peptide again.

The electrical signal changes slightly at every step.

By following those changes, researchers can gather information about the peptide’s sequence, distinguish certain mutations, and detect some chemical modifications.

The researchers call the approach “chop and measure.”

That description is surprisingly accurate.

The peptide is held in place, repeatedly measured, shortened by one amino acid, and measured again.

The technique is not yet the protein equivalent of a commercial DNA sequencer.

It does, however, offer a promising solution to one of biotechnology’s most difficult problems:

How can scientists read individual protein molecules with enough precision to identify their amino-acid sequence and the modifications that influence what those proteins do?

Why Protein Sequencing Matters

Proteins perform much of the physical and chemical work that keeps living organisms functioning.

They help build tissues, transport molecules, send signals, defend against infection, regulate genes, digest food, move muscles, and control chemical reactions.

Proteins are made from chains of amino acids.

The order of those amino acids influences how a protein folds, what shape it takes, which molecules it interacts with, and what biological function it performs.

A single amino-acid change can sometimes have major consequences.

It may weaken a protein, alter its activity, disrupt its location inside a cell, or contribute to disease.

Scientists therefore want to know more than whether a particular protein is present.

They also want to understand its exact structure, sequence, abundance, mutations, and chemical modifications.

That broader field is known as proteomics.

DNA Does Not Tell the Entire Story

Modern DNA sequencing allows scientists to read genetic information rapidly and at enormous scale.

That has transformed medicine, biology, criminal investigation, ancestry research, agriculture, and public health.

However, DNA provides the instructions used to make proteins.

It does not always reveal the final condition of the protein produced from those instructions.

After a protein is made, cells may chemically modify it.

They may add phosphate groups, sugars, lipids, or other molecular components.

Proteins may also be cut into smaller pieces, folded differently, damaged, or combined with other molecules.

These changes are known broadly as post-translational modifications.

They can alter how proteins behave without changing the underlying DNA sequence.

Two cells with the same genome can therefore contain very different proteins and perform very different functions.

That is one reason scientists cannot understand human biology through DNA alone.

Why Proteins Are Harder to Read Than DNA

DNA is constructed from four main chemical bases.

Proteins are built from 20 standard amino acids, along with additional chemical modifications that create even more possible variation.

DNA also carries a relatively uniform negative electrical charge, making it easier to move through nanopores in a controlled way.

Proteins are more complicated.

Different amino acids have different sizes, shapes, electrical charges, and chemical properties.

Proteins can fold into elaborate three-dimensional structures rather than remaining as simple linear chains.

They may also move through a nanopore too quickly or unpredictably for accurate measurement.

A nanopore can sense several amino acids near its narrowest region at the same time.

That can make it difficult to determine which individual amino acid produced a particular electrical signal.

The new study attempts to reduce that problem by keeping the peptide attached to the nanopore and repeatedly reading its end.

What Is a Nanopore?

A nanopore is an opening measured in nanometers.

A nanometer is one-billionth of a meter.

Some nanopores are manufactured from solid materials.

Others are created from naturally occurring or engineered proteins that form channels through biological membranes.

When voltage is applied across a membrane containing a nanopore, ions move through the opening and generate a measurable electrical current.

If another molecule enters or interacts with the pore, it partially blocks that current.

The size, shape, charge, and chemical properties of the molecule influence the pattern of the electrical disruption.

Researchers can analyze those patterns to infer information about the molecule.

Nanopore technology has already become important in DNA and RNA sequencing.

Applying the same general concept to proteins and peptides has proven much harder.

How the New Method Works

The researchers developed a technique called transient pore analyte looping, abbreviated as tPAL.

They engineered a nanopore based on Mycobacterium smegmatis porin A, commonly known as MspA.

The nanopore was modified with a nickel-containing molecular adapter capable of helping hold the target peptide near the pore’s sensing region.

Rather than allowing the peptide to pass through once and disappear, the system keeps it positioned so that the nanopore can read it repeatedly.

Repeated readings help reduce uncertainty.

A single measurement may contain electrical noise or natural variation.

When the system observes the same peptide end many times, researchers can develop a more reliable signal distribution.

The next part of the process is what gives the method its “chop and measure” description.

An Enzyme Removes One Amino Acid at a Time

The researchers used an aminopeptidase, an enzyme capable of removing amino acids from the amino-terminal end of a peptide.

They modified the enzyme so that it could operate near the nanopore system.

The enzyme shortened the immobilized peptide in single-amino-acid steps.

After one amino acid was removed, the nanopore repeatedly measured the new end of the shortened peptide.

The enzyme then removed another amino acid.

The system measured the peptide again.

This process produced a staircase-like series of electrical-signal changes.

Each step corresponded to a new peptide state.

Researchers could then examine those signal transitions for clues about the sequence.

The technique avoids attempting to identify every amino acid from one rapid movement through the pore.

Instead, it converts sequencing into a repeated cycle:

Measure, remove one amino acid, measure again, and compare the difference.

Why Repeated Reading Is Important

Single-molecule measurements are affected by noise.

Molecules move.

Electrical signals fluctuate.

Interactions between a peptide and a nanopore can vary slightly from one moment to another.

Repeated reading gives researchers more information about the same molecular state.

Rather than relying on one electrical event, the system can develop a cluster of measurements representing the peptide before the next amino acid is removed.

This can make small differences easier to recognize.

The approach is conceptually similar to reading a difficult word several times rather than looking at it for only a fraction of a second.

Repeated observation does not eliminate every error.

It can improve confidence that a signal pattern reflects the molecule rather than random variation.

The Researchers Reached Single-Amino-Acid Resolution

The study demonstrated that the system could follow changes occurring when a peptide was shortened one amino acid at a time.

The researchers reported sequence-dependent electrical signals and single-amino-acid resolution.

That does not mean the machine independently identified every possible protein sequence without prior knowledge.

It means the system could resolve changes occurring at the level of individual amino-acid removal and use those signals to help decode peptide sequences.

This distinction matters.

A laboratory proof of concept can demonstrate that a physical measurement contains sequence information without yet offering the accuracy, automation, or throughput required for routine use.

The achievement is still important.

Single-amino-acid resolution is one of the central technical requirements for future protein-sequencing technologies.

The Method Detected Single-Amino-Acid Mutations

The researchers also showed that the platform could distinguish peptides containing single-amino-acid mutations.

A mutation changing one amino acid can alter the electrical signal produced by the peptide end.

Detecting these subtle differences could eventually become valuable in medical research.

Certain inherited disorders and cancers are connected to changes in protein sequence.

A future technology capable of reading individual proteins could potentially help researchers determine which molecular variants are present in a sample.

However, the current study should not be interpreted as a new clinical genetic test.

The experiments involved controlled peptide systems.

Real patient samples contain extraordinarily complicated mixtures of proteins at widely different concentrations.

The Platform Detected Chemical Modifications

One of the most promising findings was the system’s ability to identify certain post-translational modifications.

These modifications can influence protein activity, location, stability, and interaction with other molecules.

Phosphorylation is one important example.

Cells often add or remove phosphate groups to regulate signaling pathways.

Abnormal phosphorylation is connected to cancer, neurodegenerative disease, immune disorders, and many other biological conditions.

Existing DNA sequencing cannot directly reveal whether a specific protein molecule has been phosphorylated.

A sufficiently advanced protein-reading platform might eventually detect the sequence and modification state of the same molecule.

That would give researchers a more direct view of what is happening inside cells.

The Method Also Recognized Unnatural Amino Acids

The study reported that the nanopore platform could distinguish certain unnatural-amino-acid insertions.

Unnatural amino acids are chemical building blocks that extend beyond the 20 standard amino acids commonly used by living cells.

Researchers use them in synthetic biology, protein engineering, chemical biology, and drug development.

They can give proteins new chemical functions or allow scientists to label and track molecules.

A sequencing technology capable of recognizing both natural and engineered amino acids could become useful for analyzing synthetic peptides, biological medicines, and designed proteins.

This potential application may be especially relevant as biotechnology companies create increasingly complex therapeutic molecules.

This Is Peptide Sequencing, Not Yet Universal Protein Sequencing

The study’s title and findings focus on peptides immobilized at a nanopore.

Peptides are chains of amino acids, but they are generally shorter than full-length proteins.

Full proteins may contain hundreds or thousands of amino acids.

They can fold into complex structures and carry many modifications.

A complete protein-sequencing system would need to capture those molecules, unfold them, control their movement, maintain the correct reading orientation, identify each amino acid accurately, and process enormous numbers of molecules.

The new method addresses important parts of that challenge.

It does not solve every part.

Calling the work a completed universal protein sequencer would overstate the evidence.

It is better understood as a promising new strategy toward single-molecule peptide and protein analysis.

How This Differs From Mass Spectrometry

Mass spectrometry is currently one of the most important tools in proteomics.

It measures molecules based partly on their mass-to-charge ratio.

Researchers often digest proteins into smaller peptides, separate those peptides, analyze their spectra, and use computational methods to identify the likely proteins.

Mass spectrometry can study thousands of proteins and many chemical modifications.

It is powerful, established, and continuously improving.

However, it may struggle with extremely rare molecules, complex mixtures, similar protein variants, and reconstructing every detail of individual full-length protein molecules.

Nanopore sequencing offers a different possibility.

In principle, it could examine individual molecules electrically and repeatedly without requiring the same type of large analytical instrument.

The two approaches should not necessarily be viewed as competitors.

Future proteomics laboratories may combine mass spectrometry, nanopores, imaging, antibody-based methods, and other technologies.

Why Single-Molecule Analysis Could Matter

Most traditional biological measurements combine signals from many molecules.

The result represents an average.

Averages can hide important differences.

Suppose a sample contains one million copies of a protein.

Most may be normal, while a small fraction carry a disease-related mutation or chemical modification.

A bulk measurement might miss the rare subgroup.

Single-molecule technologies attempt to measure molecules individually.

That could allow researchers to identify uncommon protein variants that are hidden within a much larger population.

This may become especially useful in cancer, where small groups of abnormal cells can differ from the rest of a tumor.

It could also help researchers study early disease, treatment resistance, immune responses, and rare biological events.

Possible Uses in Cancer Research

Cancer is driven by changes in genes, proteins, signaling pathways, and cell behavior.

Two tumors that appear similar under a microscope may use different molecular mechanisms.

Protein sequencing could eventually help researchers examine those differences more directly.

A nanopore platform might one day help detect abnormal protein variants, identify signaling modifications, or monitor how tumors respond to treatment.

It could also contribute to liquid-biopsy research if scientists can reliably analyze very small quantities of disease-related proteins in blood.

Those applications remain future possibilities.

The current study did not demonstrate a routine cancer-screening test.

Turning a laboratory sequencing method into a clinical platform would require extensive testing, validation, regulation, and comparison with existing diagnostic methods.

Possible Uses in Neurodegenerative Disease

Diseases such as Alzheimer’s, Parkinson’s, and other neurodegenerative conditions involve proteins that become misfolded, modified, aggregated, or abnormally processed.

Researchers are interested in identifying different molecular forms of proteins such as tau, amyloid beta, and alpha-synuclein.

A technology capable of reading individual peptide or protein molecules could potentially reveal subtle differences that existing tests overlook.

It might help scientists distinguish disease-associated forms from normal forms.

It could also support research into how protein changes develop over time.

Again, that possibility should not be confused with an immediate diagnostic breakthrough.

The method must first show that it can operate reliably in complex samples containing many competing molecules.

Drug Development Could Benefit

Biological medicines are often proteins or peptides.

These include antibodies, hormones, enzymes, vaccines, and other engineered therapeutic molecules.

Manufacturers must confirm that these products have the correct sequence, structure, purity, and chemical modifications.

Even small manufacturing differences can influence safety or effectiveness.

A high-resolution nanopore platform could eventually provide another method for checking biological products.

It might help identify sequence errors, degradation, unexpected modifications, or variation among individual molecules.

The ability to recognize unnatural amino acids could also support the development of new peptide-based medicines.

Personalized Medicine Requires More Than Genomics

Personalized medicine often focuses on genetic information.

Genes can help estimate disease risk, identify inherited variants, and guide certain treatments.

However, genes do not always reveal which proteins are active at a particular moment.

Protein measurements may provide a more immediate picture of what cells are doing.

A patient’s genome remains largely stable.

The proteome changes with age, illness, medication, nutrition, stress, infection, and environment.

Future medicine may combine genomic information with protein, metabolite, imaging, and clinical data.

More precise protein sequencing could become one piece of that broader system.

The Technology Could Help Study Rare Proteins

Some biologically important proteins exist at extremely low concentrations.

They may be difficult to detect against a background of abundant proteins.

Single-molecule nanopore methods could potentially reduce the amount of material needed for analysis.

That would be valuable when researchers have only a tiny sample.

Examples might include small biopsies, rare cell populations, limited cerebrospinal fluid, or samples collected during very early disease.

Sensitivity alone is not enough.

The system must also select the correct target from a complicated mixture and avoid confusing similar molecules.

Sample preparation and molecular capture will therefore remain major research challenges.

Accuracy Will Be a Central Question

A useful sequencing technology must produce results that can be trusted.

Electrical signals from nanopores can overlap.

Different amino-acid combinations may create similar patterns.

Chemical modifications can complicate interpretation.

The order and local environment of amino acids may influence how a signal appears.

Researchers will need large reference libraries and sophisticated computational models.

Machine learning may help classify signals and infer sequences.

However, AI cannot compensate for poor or ambiguous measurements indefinitely.

Future studies must establish error rates, repeatability, limits of detection, and performance across many peptide types.

Clinical uses would require especially demanding standards.

Reading All 20 Amino Acids Reliably Remains Difficult

Proteins contain 20 standard amino acids.

Some have substantially different chemical properties.

Others are very similar.

Leucine and isoleucine, for example, have the same molecular mass but different structures.

Distinguishing closely related amino acids is a major challenge for sequencing systems.

The “chop and measure” strategy gains information by examining how the signal changes after each removal.

That may allow researchers to decode sequences even when one individual signal is not perfectly unique.

Still, a general-purpose sequencer will need reliable discrimination across many sequence contexts.

It must also recognize modifications without mistaking them for different amino acids.

Speed and Throughput Will Determine Practical Value

A method can be scientifically impressive while remaining too slow for routine use.

Modern biological research often requires analysis of thousands or millions of molecules.

A system that reads only a small number of peptides would have limited value for large proteomic studies.

Researchers will need to determine whether the nanopore process can be automated and operated across many pores at once.

Parallelization was essential to the success of modern DNA sequencing.

A future protein-sequencing platform may similarly require large arrays of nanopores operating simultaneously.

The instrument would also need software capable of processing the resulting electrical data rapidly.

Sample Preparation Could Be the Hardest Part

A blood, tissue, or cell sample contains many different proteins.

Some are extremely abundant.

Others are rare.

Proteins may be folded, bound to other molecules, embedded in membranes, damaged, or chemically modified.

Before sequencing, researchers may need to isolate targets, break full-length proteins into suitable peptides, attach them correctly, and deliver them to the nanopore.

Every preparation step creates opportunities for bias or loss.

A technology may read a peptide accurately once it reaches the pore while still failing to represent the original biological sample fairly.

For that reason, the entire workflow matters—not only the nanopore itself.

The Study Builds on Years of Nanopore Research

The new technique did not appear from nowhere.

Researchers have spent years improving nanopore detection of amino acids, peptides, and proteins.

Previous studies demonstrated that nanopores could distinguish peptides differing by one amino acid, repeatedly read individual protein molecules, identify certain modifications, and achieve high-resolution sensing.

Other teams have developed reverse-translation strategies that convert information from amino acids into DNA barcodes.

These approaches use different mechanisms but pursue a similar goal: bringing single-molecule precision to protein analysis.

The 2026 “chop and measure” study adds another important strategy by combining repeated terminal sensing with controlled enzymatic shortening.

Competing Methods May Advance Together

It is too early to know which protein-sequencing method will ultimately become dominant.

Some researchers are developing nanopore systems.

Others are working on fluorescent labeling, DNA barcoding, modified chemical degradation, mass spectrometry, tunneling currents, and microscopy-based approaches.

Each method has advantages and limitations.

One may offer better accuracy.

Another may be faster.

Another may recognize modifications more effectively.

The future may not produce one universal technology.

Different platforms may serve different purposes, much as laboratories currently use several kinds of DNA sequencing and protein analysis.

This Is Not Ready for Consumer Testing

The research does not support commercial tests claiming to read a person’s complete proteome from a simple home sample.

Consumers should be cautious about companies using early research to market unvalidated health predictions.

A clinically useful protein-sequencing test would require clearly defined performance, independent validation, regulatory review, quality controls, and evidence that the results improve patient care.

Scientific possibility is not the same as medical readiness.

The new study expands what may eventually become possible.

It does not create an immediate reason for patients to change treatment, screening, diet, or medication.

New To Education Analysis

The significance of this research lies less in what the device can do today and more in the direction it points.

DNA sequencing became transformative after researchers learned not only how to detect genetic bases but also how to automate, parallelize, interpret, and reduce the cost of the process.

Protein sequencing faces a more complicated problem.

Proteins contain more building blocks, carry more chemical variation, fold into complex shapes, and change throughout a person’s life.

The “chop and measure” strategy is compelling because it converts a difficult continuous-reading problem into a sequence of smaller comparisons.

Instead of asking a nanopore to understand an entire fast-moving protein immediately, the method holds a peptide, reads it repeatedly, removes one amino acid, and asks what changed.

That is an elegant scientific idea.

Its long-term value will depend on whether researchers can make it accurate, fast, scalable, and compatible with real biological samples.

If they can, biotechnology may gain a tool that does for proteins some of what sequencing already did for DNA.

Why This Research Matters for Education

This study also offers a useful example of how modern scientific breakthroughs develop.

The researchers did not solve protein sequencing through one isolated invention.

They combined microbiology, protein engineering, chemistry, enzyme design, electronics, data analysis, and previous nanopore research.

Students considering biotechnology careers should recognize that major advances increasingly occur at the intersection of several fields.

Future researchers may need to understand biology while also working with computer science, engineering, statistics, and artificial intelligence.

The study is therefore not only about a new device.

It reflects how scientific education itself is changing.

Key Takeaways

Researchers developed a nanopore-based method that repeatedly reads an immobilized peptide while an enzyme shortens it one amino acid at a time.

The technique is called transient pore analyte looping, or tPAL, and has been described as a “chop and measure” strategy.

Each shortening step produces a change in the nanopore’s electrical signal, giving researchers information that can help decode the peptide sequence.

The method achieved single-amino-acid resolution and distinguished certain single-amino-acid mutations, post-translational modifications, and unnatural-amino-acid insertions.

The research focuses on experimental peptide sequencing and should not be described as a complete universal system for sequencing every full-length protein.

Potential future applications include cancer research, drug development, neurodegenerative-disease research, biological medicine manufacturing, and personalized medicine.

Major challenges remain involving accuracy, speed, sample preparation, complex biological mixtures, full-length proteins, automation, and large-scale throughput.

Frequently Asked Questions

What is an amino acid?

An amino acid is a chemical building block used to construct proteins. Human proteins primarily use 20 standard amino acids arranged in different sequences.

What is a peptide?

A peptide is a chain of amino acids. Peptides are generally shorter than full-length proteins, although the distinction can vary depending on context.

What is a nanopore?

A nanopore is an extremely small opening through which ions and molecules can interact. Changes in electrical current across the pore can reveal information about a molecule.

Did the researchers sequence a complete human protein?

The study demonstrated sequencing-related analysis of immobilized peptides. It did not establish routine sequencing of every type of complete human protein.

What does “single-amino-acid resolution” mean?

It means the system can detect changes occurring at the scale of one amino acid rather than only recognizing large sections of a peptide.

Why does the enzyme remove amino acids?

Removing one amino acid at a time creates a sequence of slightly shorter peptides. Measuring the electrical change after each removal provides clues about the sequence.

Can this diagnose cancer today?

No. The method remains an experimental research platform and has not been established as a routine clinical diagnostic test.

Could it replace mass spectrometry?

It is too early to know. Nanopore sequencing may eventually complement mass spectrometry and other protein-analysis tools rather than replace them completely.

Why are proteins harder to sequence than DNA?

Proteins use more building blocks, have varied electrical properties, fold into complex shapes, and carry chemical modifications that are not directly represented in DNA.

What happens next?

Researchers will need to improve accuracy, throughput, automation, full-length protein handling, computational interpretation, and performance in complex biological samples.

Final Thoughts

Scientists have spent decades learning how to read the molecules of life.

DNA sequencing revealed the instructions.

Protein sequencing may help reveal how those instructions are actually carried out.

The new nanopore method does not yet provide a complete answer.

It offers a clever way forward.

By repeatedly measuring a peptide and removing one amino acid at a time, researchers transformed a difficult molecular problem into a controlled sequence of comparisons.

That could eventually help scientists detect rare protein variants, examine disease-related modifications, analyze engineered medicines, and understand biological differences that DNA alone cannot explain.

The distance between a laboratory demonstration and a widely used medical technology remains substantial.

Accuracy must improve.

The system must become faster.

Full-length proteins and complex samples must be managed.

Clinical value must be proven.

Still, many transformative technologies begin with an experiment showing that something previously considered extremely difficult is physically possible.

Reading proteins one amino acid at a time is moving closer to that point.

Support New To Education

New To Education publishes accessible coverage of biotechnology, health research, artificial intelligence, education, business, and the scientific developments shaping how people learn and prepare for the future.

Readers can support New To Education by sharing our articles, joining our community, subscribing to our updates, and exploring the educational and professional services available through our platform.

Visit New To Education

AI-Designed Proteins Could Reveal Previously Hidden Activity Inside Living Cells

Innovation Watch: Harvard Scientists Turn a Silicon Chip Into a DNA-Writing Machine

Why New To Education Publishes News, Research, and Educational Analysis